Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants - Related Studies

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

This study is ongoing, but not recruiting participants.

Study NCT00433485. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Neoplastic Syndrome
		Non-Melanomatous Skin Cancer

2	Additional conditions recognized in this trial
		Basal Cell Nevus Syndrome
		Skin Neoplasms
		Syndrome

3	More general conditions related to this trial
		Abnormalities, Multiple
		Bone Cysts
		Bone Diseases
		Bone Diseases, Developmental
		Carcinoma
		Carcinoma, Basal Cell
		Congenital Abnormalities
		Cysts
		Disease
		Genetic Diseases, Inborn
		Jaw Cysts
		Jaw Diseases
		Musculoskeletal Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Basal Cell
		Neoplasms, Glandular and Epithelial
		Neoplastic Syndromes, Hereditary
		Odontogenic Cysts
		Pathologic Processes
		Skin Diseases
		Stomatognathic Diseases

4	Interventions listed in this trial
		sirolimus
		biopsy
		comparative genomic hybridization
		gene expression analysis
		gene expression profiling
		laboratory biomarker analysis
		mass spectrometry
		protein expression analysis
		proteomic profiling

5	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antifungal Agents
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Yale University
		National Cancer Institute (NCI)